Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
acknowledged, adhesive, Adiana, allergic, alleviated, autoimmune, biologically, bodily, Brian, Broadway, ceasing, chronic, classed, coil, complained, conceptually, consumed, copper, DAEN, depletion, detached, diathermy, difficulty, disaggregated, discretionary, doomsday, Dr, drinking, EBITDA, ectopic, empirically, encapsulation, encompassed, English, expert, explanation, Fax, fluctuation, GILTI, grew, Haynie, Hologic, incorrectly, indirectly, inert, inflammatory, inventor, journal, Koopman, loaded, macroeconomic, massively, maturity, meant, menstrual, metal, metric, microbiology, minute, nickel, OPM, Orthopedic, overpayment, perforation, person, Perversely, politically, prepaid, prevalent, rare, rarely, rationale, recourse, regeneration, renamed, resaleable, scar, SE, short, social, solid, spite, squeezed, straight, subdued, Suite, TCJA, TGA, titanium, toxicology, transcervically, understood, unneeded, variable, variance, war, water, wipe, worth
Removed:
absorption, accelerated, assumed, blocked, Branch, Chase, competing, confirm, decrease, enacting, freely, full, implant, indemnity, insurer, interim, JP, JPMorgan, LLC, loan, London, marginal, misapplication, Morgan, nikomed, partum, reportedly, reversible, targeting, tradeable, transvaginally, typical
Filing tables
Filing exhibits
- 10-K Annual report
- 10.5 Summary of Officer and Director Compensation
- 21.1 Subsidiaries of Utah Medical Products, Inc.
- 23.1 Consent of Haynie & Company, Utmd's Independent Auditors for the Year Ended December 31, 2018
- 23.2 Consent of Jones Simkins LLC, Utmd's Independent Auditors for the Years Ended December 31, 2017 and December 31, 2016
- 23.3 Consent of Nortons Assurance Limited, Femcare Group Limited's Independent Auditors for the Years Ended December 31, 2018, December 31, 2017 and December 31, 2016
- 31.1 Certification of CEO Pursuant to Rule 13A-14(A) As Adopted Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 31.2 Certification of Principal Financial Officer Pursuant to Rule 13A-14(A) As Adopted Pursuant to Section 302 of the Sarbanes-oxley Act of 2002
- 32.2 Certification of CEO Pursuant to 18 U.s.c. ?1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- 32.2 Certification of Principal Financial Officer Pursuant to 18 U.s.c. ?1350, As Adopted Pursuant to Section 906 of the Sarbanes-oxley Act of 2002
- Download Excel data file
- View Excel data file
Related press release
UTMD similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Utah Medical Products, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2018, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian L. Koopman, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:
| (1) | the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
/s/ Brian L. Koopman
Brian L. Koopman
Principal Financial Officer
March 12, 2019
A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.